U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Growth Opportunity, 2025-2034

Table of Contents

    1. Introduction
        1.1. Report Description
            1.1.1.  Objectives of the Study
            1.1.2.  Market Scope
            1.1.3.  Assumptions
        1.2. Stakeholders
    2. Executive Summary
        2.1. Market Highlights
    3. Research Methodology
        3.1. Overview
            3.1.1.  Data Mining
        3.2. Data Source
            3.2.1.  Primary Source
            3.2.2.  Secondary Source
    4. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Insights
        4.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Market Snapshot
        4.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
            4.2.1.  Drivers and Opportunities
                4.2.1.1. Rising Expenditure on Animal Health
                4.2.1.2. Increasing Investment in Facility Expansion
            4.2.2.  Restraints and Challenges
                4.2.2.1. Stringent Regulation
        4.3. Porter’s Five Forces Analysis
            4.3.1.  Bargaining Power of Suppliers (Moderate)
            4.3.2.  Threats of New Entrants: (Low)
            4.3.3.  Bargaining Power of Buyers (Moderate)
            4.3.4.  Threat of Substitute (Moderate)
            4.3.5.  Rivalry among existing firms (High)
        4.4. PESTEL Analysis
        4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends
        4.6. Value Chain Analysis
    5. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type
        5.1. Key Findings
        5.2. Introduction
            5.2.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
        5.3. In-House
            5.3.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by In-House, by Region, 2020-2034 (USD Billion)
        5.4. Contract Outsourcing
            5.4.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Outsourcing, by Region, 2020-2034 (USD Billion)
            5.4.2. Contract Development
                5.4.2.1.  U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Development, by Region, 2020-2034 (USD Billion)
                5.4.2.2. Preclinical Development
                    5.4.2.2.1.  U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Preclinical Development, by Region, 2020-2034 (USD Billion)
                5.4.2.3. Clinical Development
                    5.4.2.3.1.  U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Clinical Development, by Region, 2020-2034 (USD Billion)
            5.4.3. Contract Manufacturing
                5.4.3.1.  U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Manufacturing, by Region, 2020-2034 (USD Billion)
    6. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type
        6.1. Key Findings
        6.2. Introduction
            6.2.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
        6.3. Chemical-based API
            6.3.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Chemical-based API, by Region, 2020-2034 (USD Billion)
        6.4. Biological API
            6.4.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Biological API, by Region, 2020-2034 (USD Billion)
        6.5. HPAPI
            6.5.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by HPAPI, by Region, 2020-2034 (USD Billion)
    7. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type
        7.1. Key Findings
        7.2. Introduction
            7.2.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
        7.3. Production Animals
            7.3.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Production Animals, by Region, 2020-2034 (USD Billion)
        7.4. Companion Animals
            7.4.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Companion Animals, by Region, 2020-2034 (USD Billion)
    8. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category
        8.1.  Key Findings
        8.2.  Introduction
            8.2.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
        8.3. Antiparasitics
            8.3.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Antiparasitics, by Region, 2020-2034 (USD Billion)
        8.4. Anti-infectives
            8.4.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Anti-infectives, by Region, 2020-2034 (USD Billion)
        8.5. NSAIDs
            8.5.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by NSAIDs, by Region, 2020-2034 (USD Billion)
        8.6. Others
            8.6.1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)
    9. Competitive Landscape
        9.1. Expansion and Acquisition Analysis
            9.1.1. Expansion
            9.1.2. Acquisitions
        9.2. Partnerships/Collaborations/Agreements/Exhibitions
    10. Company Profiles
        10.1. Alivira Animal Health Limited
            10.1.1. Company Overview
            10.1.2. Financial Performance
            10.1.3. Product Benchmarking
            10.1.4. Recent Development
        10.2. Bimeda Inc.
            10.2.1. Company Overview
            10.2.2. Financial Performance
            10.2.3. Product Benchmarking
            10.2.4. Recent Development
        10.3. Excel Industries Limited
            10.3.1. Company Overview
            10.3.2. Financial Performance
            10.3.3. Product Benchmarking
            10.3.4. Recent Development
        10.4. Elanco Animal Health 
            10.4.1. Company Overview
            10.4.2. Financial Performance
            10.4.3. Product Benchmarking
            10.4.4. Recent Development
        10.5. FIS - Fabbrica Italiana Sintetici S.p.A. 
            10.5.1. Company Overview 
            10.5.2. Financial Performance
            10.5.3. Product Benchmarking
            10.5.4. Recent Development
        10.6. Huateng Pharma
            10.6.1. Company Overview
            10.6.2. Financial Performance
            10.6.3. Product Benchmarking
            10.6.4. Recent Development
        10.7. Huvepharma AD
            10.7.1. Company Overview
            10.7.2. Financial Performance
            10.7.3. Product Benchmarking
            10.7.4. Recent Development
        10.8. Merck Animal Health
            10.8.1. Company Overview
            10.8.2. Financial Performance
            10.8.3. Product Benchmarking
            10.8.4. Recent Development
        10.9. Ofichem Group B.V.
            10.9.1. Company Overview
            10.9.2. Financial Performance
            10.9.3. Product Benchmarking
            10.9.4. Recent Development 
        10.10. Phibro Animal Health Corporation
            10.10.1. Company Overview
            10.10.2. Financial Performance
            10.10.3. Product Benchmarking
            10.10.4. Recent Development
        10.11. Rochem International Inc.
            10.11.1. Company Overview
            10.11.2. Financial Performance
            10.11.3. Product Benchmarking
            10.11.4. Recent Development
        10.12. SUANFARMA S.A
            10.12.1. Company Overview
            10.12.2. Financial Performance
            10.12.3. Product Benchmarking
            10.12.4. Recent Development
        10.13. Zoetis Inc.
            10.13.1. Company Overview
            10.13.2. Financial Performance
            10.13.3. Product Benchmarking
            10.13.4. Recent Development

    List of Tables:

    Table 1 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    Table 2 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    Table 3 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    Table 4 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)

    List of Figures:

    Figure 1. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, 2020-2034 (USD Billion)
    Figure 2. Integrated Ecosystem
    Figure 3. Research Methodology: Top-Down & Bottom-Up Price
    Figure 4. Market by Geography
    Figure 5. Porter’s Five Forces
    Figure 6. Market by Service Type
    Figure 7. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2024 & 2034 (USD Billion)
    Figure 8. Market by Synthesis Type
    Figure 9. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2024 & 2034 (USD Billion)
    Figure 10. Market by Animal Type
    Figure 11. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2024 & 2034 (USD Billion)
    Figure 12. Market by Therapeutic Category
    Figure 13. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2024 & 2034 (USD Billion)